Skip to main content

Correction to: pH of anti-VEGF agents in the human vitreous: low impact of very different formulations

The Original Article was published on 26 June 2017

Correction to: Int J Retin Vitr (2017) 3:22 DOI 10.1186/s40942-017-0075-x

After the publication of this article [1], we were made aware that the osmolarity of aflibercept (Eylea) was incorrect and should have been 286 mOsm and not 1000 mOsm. The correct version of Table 1 is shown in this correction (Table 1).

Table 1 The formulations and pH values of anti-VEGF agents

Reference

  1. Sobolewska B et al. pH of anti-VEGF agents in the human vitreous: low impact of very different formulations. Int J Retin Vitr. 2017;3:22. doi:10.1186/s40942-017-0075-x

    Article  Google Scholar 

Download references

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Bianka Sobolewska.

Additional information

The online version of the original article can be found under doi:10.1186/s40942-017-0075-x.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sobolewska, B., Heiduschka, P., Bartz‑Schmidt, K. et al. Correction to: pH of anti-VEGF agents in the human vitreous: low impact of very different formulations. Int J Retin Vitr 3, 45 (2017). https://doi.org/10.1186/s40942-017-0097-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s40942-017-0097-4